Intrauterine growth restriction: fetal programming of hypertension and kidney disease.
about
Reduced Uterine Perfusion Pressure (RUPP) Model of Preeclampsia in MiceMaternal protein-energy malnutrition during early pregnancy in sheep impacts the fetal ornithine cycle to reduce fetal kidney microvascular development.Excess maternal salt intake produces sex-specific hypertension in offspring: putative roles for kidney and gastrointestinal sodium handlingGestational protein restriction increases angiotensin II production in rat lung.Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy.Circulating and Vascular Bioactive Factors during Hypertension in Pregnancy.Important issues in developmental toxicity testing.Angiotensin II receptors and drug discovery in cardiovascular disease.Short- and long-term reproductive effects of prenatal and lactational growth restriction caused by maternal diabetes in male ratsProtein-energy malnutrition during early gestation in sheep blunts fetal renal vascular and nephron development and compromises adult renal functionEffect of corticosteroids on cardiac function in growth-restricted fetuses.Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn.A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model.Changed salt appetite and central angiotensin II-induced cellular activation in rat offspring following hypoxia during fetal stages.A Low-Protein Diet Enhances Angiotensin II Production in the Lung of Pregnant Rats but not Nonpregnant Rats.Pregnancy Complications and Later Development of Hypertension.Fetal echocardiography and pulsed-wave Doppler ultrasound in a rabbit model of intrauterine growth restriction.Hyperelastic remodeling in the intrauterine growth restricted (IUGR) carotid artery in the near-term fetusEarly life stress sensitizes the renal and systemic sympathetic system in rats.N-Methyl-D-aspartate Receptor Excessive Activation Inhibited Fetal Rat Lung Development In Vivo and In VitroEarly life stress enhances angiotensin II-mediated vasoconstriction by reduced endothelial nitric oxide buffering capacitySex differences in the developmental origins of hypertension and cardiorenal disease.Influence of the Expression of Inflammatory Markers on Kidney after Fetal Programming in an Experimental Model of Renal Failure.Mending a growth-restricted fetal heart: should we use glucocorticoids?Effects of a restricted fetal growth environment on human kidney morphology, cell apoptosis and gene expression.Maternal hypomagnesemia alters renal function but does not program changes in the cardiovascular physiology of adult offspring.Placental Stem Villus Arterial Remodeling Associated with Reduced Hydrogen Sulfide Synthesis Contributes to Human Fetal Growth Restriction.Global burden of maternal and child undernutrition and micronutrient deficiencies.Environments for Healthy Living (EFHL) Griffith birth cohort study: background and methods.Restricted nutrition-induced low birth weight, low number of nephrons and glomerular mesangium injury in Japanese quail.Low molecular weight heparin treatment during subsequent pregnancies of women with inherited thrombophilia and previous severe pregnancy complications.Excessive Activation of NMDA Receptors Induced Neurodevelopmental Brain Damage and Cognitive Deficits in Rats Exposed to Intrauterine Hypoxia.Tenofovir during pregnancy in rats: a novel pathway for programmed hypertension in the offspring.
P2860
Q30382673-98DBA9B8-E828-4F1F-82CD-E826D9BD61BBQ30596717-8EEC1C86-DC92-4F79-B727-6ABECC2C59ADQ31133231-01E8836D-5CFC-4BA1-950E-0B181BD5DB47Q33581546-F2194CD8-1F2B-4DCE-8EA2-C5A9827440B9Q33793455-B12A4493-BFD7-4702-895F-A1D3DAA596C6Q33799413-FD079CD5-BF20-4F3C-86FD-6486A6734B78Q34359606-2759284B-7DB9-4B06-B572-9A6BCFE1261DQ34496676-4BAEC42E-0077-4E41-A29C-41ED0421527BQ35640878-23BF2F24-E43F-4D39-B038-CEAFFA69D543Q35748939-FA59D8F4-D52E-4E30-AC7C-5175705FC896Q35770011-634AAE27-EE72-4BFD-A1FD-AE932EB2293AQ36105461-6E63B180-B678-4107-A019-AD2BE413A33CQ36115311-A8C4FBDE-FA84-4CCB-B49B-D714EB9E8D2FQ36636088-882F0EFA-EFF8-4CC4-807A-D8F3A906AA64Q36861080-A9E42785-1322-4B28-853B-F11CB260138EQ37057315-43CCA11F-B1E7-4787-B07E-1D2BCE42B0DFQ37059704-C79F86F9-E04A-4245-81AF-9D32117BE59AQ37092181-EF4ED375-A310-4A66-B3BD-C736412DE33DQ37093655-6ADA6AF5-0A27-4F83-A689-C7F7F7BA3703Q37120680-B2A3C9B9-7CDF-4A47-A9BD-7D4B32E52295Q37125506-E41E7789-E100-4431-93BB-6D76FA019EC5Q37200124-C4139681-F6D7-4E14-AC73-413A9427099EQ37492648-62D3DE23-2C99-4C17-B501-3B473F7C31CEQ38024127-047DD251-55FE-4C39-9A41-D9921EC6D9A4Q39120686-8E6E7978-700C-4C3D-85E2-566866CA96E2Q39885441-B1336322-5715-4A3D-8002-6FD6E3794272Q41630132-037D7CD4-9644-447A-98B9-C0E08AD00DEBQ42274428-B29D898A-4051-4855-B50F-ED7065019D04Q42635230-01D69CEB-434C-4F0B-A179-76211583EC74Q47237514-879D92BB-8732-4C6F-91CF-066E87FE32BCQ47396374-4D4E3E41-264B-46A0-A587-289296760384Q47904988-16119DE0-8293-4790-B4E1-DF87D0E96C47Q51070026-7B2066E3-13EF-4EA4-8DBD-DC37C3250854
P2860
Intrauterine growth restriction: fetal programming of hypertension and kidney disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Intrauterine growth restriction: fetal programming of hypertension and kidney disease.
@ast
Intrauterine growth restriction: fetal programming of hypertension and kidney disease.
@en
type
label
Intrauterine growth restriction: fetal programming of hypertension and kidney disease.
@ast
Intrauterine growth restriction: fetal programming of hypertension and kidney disease.
@en
prefLabel
Intrauterine growth restriction: fetal programming of hypertension and kidney disease.
@ast
Intrauterine growth restriction: fetal programming of hypertension and kidney disease.
@en
P2860
P1476
Intrauterine growth restriction: fetal programming of hypertension and kidney disease.
@en
P2093
Barbara T Alexander
Daniela Grigore
P2860
P304
P356
10.1053/J.ACKD.2008.01.001
P50
P577
2008-04-01T00:00:00Z